BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38151358)

  • 1. Prognostic Impact of Primary Tumor Sidedness in Stage III Colorectal Cancer: Real-World Evidence from a Brazilian Cohort.
    Protásio BM; de Castria TB; Natalino R; Mangone FR; Saragiotto DF; Sabbaga J; Hoff PM; Chammas R
    Clin Colorectal Cancer; 2024 Mar; 23(1):73-84. PubMed ID: 38151358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCOT: Tumor Sidedness and the Influence of Adjuvant Chemotherapy Duration on Disease Free Survival (DFS).
    Saunders MP; Iype R; Kelly C; Crosby J; Kerr R; Harkin A; Allan K; McQueen J; Pearson SR; Cassidy J; Medley LC; Raouf S; Harrison M; Brewster A; Rees C; Ellis R; Thomas AL; Churn M; Iveson T; Maka N
    Clin Colorectal Cancer; 2023 Jun; 22(2):231-237. PubMed ID: 36967267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location.
    Ben-Aharon I; Goshen-Lago T; Sternschuss M; Morgenstern S; Geva R; Beny A; Dror Y; Steiner M; Hubert A; Idelevich E; Shulman K; Mishaeli M; Man S; Liebermann N; Soussan-Gutman L; Brenner B
    Oncologist; 2019 Aug; 24(8):e696-e701. PubMed ID: 30755502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Relevance of Primary Tumor Sidedness in Early-stage Colorectal Cancer: An Integrated Analysis of 4 Randomized Controlled Trials (JCOG2003A).
    Ouchi A; Sadachi R; Hamaguchi T; Tsukamoto S; Shimada Y; Inomata M; Takii Y; Komori K; Shiomi A; Shiozawa M; Ohue M; Watanabe J; Ito M; Kawashima Y; Kobatake T; Souda H; Saida Y; Hashimoto T; Sano Y; Kanemitsu Y;
    Ann Surg; 2024 Feb; 279(2):283-289. PubMed ID: 37551612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Primary Tumor Sidedness for Unresectable Stage IV Colorectal Cancer: A Retrospective Study.
    Shida D; Tanabe T; Boku N; Takashima A; Yoshida T; Tsukamoto S; Kanemitsu Y
    Ann Surg Oncol; 2019 May; 26(5):1358-1365. PubMed ID: 30719633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).
    Huemer F; Thaler J; Piringer G; Hackl H; Pleyer L; Hufnagl C; Weiss L; Greil R
    BMC Cancer; 2018 Jan; 18(1):11. PubMed ID: 29298682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of sidedness of colorectal cancer on tumor immunity.
    Takasu C; Nishi M; Yoshikawa K; Tokunaga T; Kashihara H; Yoshimoto T; Shimada M
    PLoS One; 2020; 15(10):e0240408. PubMed ID: 33045001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status.
    Taieb J; Kourie HR; Emile JF; Le Malicot K; Balogoun R; Tabernero J; Mini E; Folprecht G; Van Laethem JL; Mulot C; Bouché O; Aparicio T; Michel P; Thaler J; Bridgewater J; Van Cutsem E; Perkins G; Lepage C; Salazar R; Laurent-Puig P;
    JAMA Oncol; 2018 Jul; 4(7):e173695. PubMed ID: 29167892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer.
    Yin J; Cohen R; Jin Z; Liu H; Pederson L; Adams R; Grothey A; Maughan TS; Venook A; Van Cutsem E; Punt C; Koopman M; Falcone A; Tebbutt NC; Seymour MT; Bokemeyer C; Rubio ED; Kaplan R; Heinemann V; Chibaudel B; Yoshino T; Zalcberg J; Andre T; De Gramont A; Shi Q; Lenz HJ
    J Natl Cancer Inst; 2021 Nov; 113(12):1705-1713. PubMed ID: 34061178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of primary tumor location in Stage III colorectal cancer-right-sided colon versus left-sided colon versus rectum: a nationwide multicenter retrospective study.
    Shida D; Inoue M; Tanabe T; Moritani K; Tsukamoto S; Yamauchi S; Sugihara K; Kanemitsu Y
    J Gastroenterol; 2020 Oct; 55(10):958-968. PubMed ID: 32651860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of primary tumor sidedness and sex on unresectable post-recurrence survival in resected pathological stage II-III colorectal cancers: a nationwide multicenter retrospective study.
    Abe S; Kawai K; Nozawa H; Sasaki K; Murono K; Emoto S; Ozawa T; Yokoyama Y; Nagai Y; Anzai H; Sonoda H; Yamauchi S; Sugihara K; Ishihara S
    BMC Cancer; 2022 May; 22(1):486. PubMed ID: 35501727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Significance of Sidedness in Patients with Metastatic Colorectal Cancer Treated with Triplet First-line Chemotherapy.
    Bazarbashi S; Omar AT; Raddaoui L; Badran A; Alzahrani A; Aljubran A; Elhassan T
    Asian Pac J Cancer Prev; 2019 Oct; 20(10):2891-2896. PubMed ID: 31653131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab.
    Pentheroudakis G; Mavroeidis L; Papadopoulou K; Koliou GA; Bamia C; Chatzopoulos K; Samantas E; Mauri D; Efstratiou I; Pectasides D; Makatsoris T; Bafaloukos D; Papakostas P; Papatsibas G; Bombolaki I; Chrisafi S; Kourea HP; Petraki K; Kafiri G; Fountzilas G; Kotoula V
    Clin Colorectal Cancer; 2019 Dec; 18(4):e370-e384. PubMed ID: 31402291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of tumor-infiltrating lymphocytes with survival depends on primary tumor sidedness in stage III colon cancers (NCCTG N0147) [Alliance].
    Saberzadeh-Ardestani B; Foster NR; Lee HE; Shi Q; Alberts SR; Smyrk TC; Sinicrope FA
    Ann Oncol; 2022 Nov; 33(11):1159-1167. PubMed ID: 35963480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Effect of Tumor Sidedness in Colorectal Cancer: A SEER-Based Analysis.
    Li Y; Feng Y; Dai W; Li Q; Cai S; Peng J
    Clin Colorectal Cancer; 2019 Mar; 18(1):e104-e116. PubMed ID: 30448100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of colorectal cancer patients with bone metastases: a single-center experience.
    Li T; Jing H; Zhang Y; Cao Z; Zhao L; Zhang X; Sun T; Zhang M
    Updates Surg; 2023 Dec; 75(8):2245-2256. PubMed ID: 37976001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies.
    Boeckx N; Koukakis R; Op de Beeck K; Rolfo C; Van Camp G; Siena S; Tabernero J; Douillard JY; André T; Peeters M
    Ann Oncol; 2017 Aug; 28(8):1862-1868. PubMed ID: 28449055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study.
    Atci MM; Akagunduz B; Demir M; Arikan R; Ay S; Ozer M; Ayhan M; Cil I; Demir N; Ozyurt N; Karakaya G; Cevik GT; Onder AH; Selvi O; Sakin A
    J Chemother; 2023 Feb; 35(1):19-28. PubMed ID: 35174772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of primary tumor sidedness on survival in early-onset colorectal cancer by stage: A National Veterans Affairs retrospective analysis.
    Azar I; Al Masalmeh N; Esfandiarifard S; Virk G; Kiwan W; Frank Shields A; Mehdi S; Philip PA
    Cancer Med; 2021 May; 10(9):2987-2995. PubMed ID: 33797856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary tumor side is associated with prognosis of colorectal cancer patients with brain metastases.
    Bergen ES; Scherleitner P; Ferreira P; Kiesel B; Müller C; Widhalm G; Dieckmann K; Prager G; Preusser M; Berghoff AS
    ESMO Open; 2021 Jun; 6(3):100168. PubMed ID: 34098230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.